DNA can voyage along intercellular highways called tunneling nanotubes. It’s a phenomenon that could potentially spread tumor ...

In Lilly's Libretto-432 ASCO readout, Retevmo showed an 83% reduction in disease progression or death when used as an adjuvant therapy in patients with early-stage RET fusion-positive lung cancer.

The phase III data from the LIBRETTO clinical trial have confirmed the importance of selective RET (REarranged during ...

Annual Meeting will be held in Chicago from May 29 to June 2, local time. Two registrational studies of the trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug conjugate ...

A new study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center shows that the targeted cancer ...

When it comes to cancer, tumor suppressor genes are usually thought of as the "good guys." These genes make proteins that ...

An experimental vaccine from Moderna shows promise in keeping deadly skin cancer from returning for years, according to new clinical trial results.

The discovery challenges the long-standing idea that early humans mainly evolved and survived in open grasslands, coasts, or other less demanding environments.

Cancer cells evolve under constant pressure from oncogene activation, hypoxia, nutrient limitation, immune surveillance, and therapeutic exposure. These ...

A new review article brings attention to the critical role of DNA methylation heterogeneity in shaping the tumor microenvironment, highlighting its growing importance in understanding cancer ...

Researchers suggest MutationProjector offers a unifying framework for connecting tumor genotypes to biological mechanisms and therapeutic outcomes.